MYWOT
Child safety
Confidence
Trustworthiness
Confidence
MALICIOUS CONTENT INDICATORS
Delmarpharma.com most likely does not offer any malicious content.
Secure connection support
HTTPS
Delmarpharma.com provides SSL-encrypted connection.
ADULT CONTENT INDICATORS
Delmarpharma.com most likely does not offer any adult content.
Popular pages
-
DelMar Pharmaceuticals
Breakthrough Cancer Therapeutics VAL-083 a modern and unique cancer chemotherapy, being developed to treat glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer, and other...
-
Publications
Investigational clinical study of VAL-083 in adult patients with recurrent glioblastoma multiforme (GBM) previously treated with surgery and/or radiation and failed both Temodar® (temozolomide) and Av...
-
Del Mar Pharmaceuticals - Home
Del Mar Pharma's first product candidate, VAL-083, benefits from an historical investment of more than US$50 million by the National Cancer Institute (NCI) in…
-
Del Mar Pharmaceuticals - VAL-083 for Recurrent Glioblastoma Multiforme (GBM) brain cancer
Jeffrey Bacha, B.Sc., MBA, Chairman, President & CEO/cofounder Mr. Bacha is a seasoned executive leader with nearly twenty years of life sciences experience in the areas of operations, strategy and f...
-
Del Mar Pharmaceuticals
15 0.05 (4.55%) 1.10 / 1.15 Previous Close 1.10 Open 1.10 Daily Range 1.15 – 1.10 52wk Range 3.40 – 1.00 Volume 55,000 Dividend N/A Avg Vol (3m) 9,559 Yield N/
-
Contact Us | Delmar Canadian Pharmacy
Corporate Headquarters of Online Canadian Pharmacy: Suite 115 – 887 Great Northern Way Vancouver, British Columbia Canada V5T 4T5 Research & Clinical Trials…